[1] |
SHI Yanlei, ZHANG Bing, WANG Yu, XU Zhuoxin, TIAN Min, MENG Min, SA Rina.
Doxorubicin-Induced Cardiotoxicity Related to Regulation of Mitochondrial-Associated Membranes by PDK4
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 863-868.
|
[2] |
CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian.
Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
|
[3] |
CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing.
Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
|
[4] |
SUN Yinghao, ZANG Shuangyao, YU Wenhui, GUO Shuai, LI Tingting, ZHANG Yi, ZHANG Tingjian, MENG Fanhao.
Effects and Challenges of Pharmacology and Toxicology of Aconitum Diterpenoid Alkaloids
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 601-607.
|
[5] |
LIU Yiyu, LI Yanwen, WANG Jiao, ZHOU Wenjing, PENG Yumeng, HE Wenbin, LI Zhiyong.
Efficacy Semantic Mining and Safety Analysis of Chinese Patent Medicines for Headache
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 674-679.
|
[6] |
MEI Haonan, ZHANG Ziyi, WANG Yuxi, WANG Hui, GUO Yu.
Developmental Toxicity and Mechanisms of Acetaminophen Exposure during Pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 702-707.
|
[7] |
ZHENG Kaifan, LENG Hongxu, XU Kaixuan, CAI Wenlu, ZHANG Ying, ZHAO Pengfei, TAN Shengjie, XIN Guizhong.
Research Progress on Intestinal Safety of Anthraquinone Laxatives
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 708-713.
|
[8] |
CHEN Runji, SUN Xiaorui, HUANG Xin, JIANG Zhenzhou, ZHANG Luyong, WANG Xinzhi, DING Jian.
Dynamic Immunophenotyping of NK Cells in Triptolide-Induced Hepatotoxicity
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 517-522.
|
[9] |
ZHANG Huiting, LI Youlin, LI Lei, YAN Yue, YAO Ting, LI Chunlei, SHI Qi.
Toxicity of Single-Dose and Repeated-Dose Administration of Guisha Zichuan Granules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 547-553.
|
[10] |
FAN Liping, LU Shu, SUN Huiyuan.
Efficacy and Safety of Panax Quinquefolium Saponin in Adjuvant Treatment of Angina Pectoris of Coronary Heart Disease: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 570-574.
|
[11] |
WANG Fengxin, LI Lei, HUANG Xurui, ZHAO Yun, LING Ruby, YANG Yang, LIANG Changhao, ZENG Yuntao, ZHENG Yingjun, TANG Yuanchen, LIU Jiatao, WANG Chengxiang, WEN Tiancai, LI Ping.
Efficacy and Safety of Danshen Decoction in Treatment of Coronary Heart Disease
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 575-579.
|
[12] |
MENG Xianghui, SUN Jiabei, Li Wenlong, JIA Juanjuan, CHENG Ming, HUANG Haiwei, SHI Yaqin.
Zebrafish Toxicity of Trimethylsilanol: an Introduced Impurity in Fludeoxyglucose [18F] Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 397-402.
|
[13] |
CHEN Lingbin, HUANG Zhixiong, ZHENG Cailin, WU Jinneng, CHEN Zhou.
Adverse Event Signals for Osimertinib-Induced Muscle Toxicity Based on FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 447-451.
|
[14] |
LUO Wen, WU Jing, HE Dake, YANG Rui.
One Case of Dermatitis Medicamentosa in a Paediatric Epilepsy Patient Caused by Lacosamide Oral Solution
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 452-455.
|
[15] |
ZHU Zhipeng, LYU Qiang, YE Xiaofei, GUO Xiaojing.
Disproportionality of Adverse Events to KRAS G12C Inhibitors Based on the FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 297-304.
|